Literature DB >> 2013435

Interleukin 1 in ulcerative colitis.

P Gionchetti, M Campieri, A Belluzzi, P Boni, C Brignola, H Ferretti, P Iannone, M Miglioli, L Barbara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013435      PMCID: PMC1378850          DOI: 10.1136/gut.32.3.338-a

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Biopsy studies in ulcerative colitis.

Authors:  S C TRUELOVE; W C RICHARDS
Journal:  Br Med J       Date:  1956-06-09

2.  Interleukin 1 in Crohn's disease.

Authors:  J Satsangi; R A Wolstencroft; J Cason; C C Ainley; D C Dumonde; R P Thompson
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

3.  Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.

Authors:  M Ligumsky; P L Simon; F Karmeli; D Rachmilewitz
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

  3 in total
  3 in total

1.  Protective effects of black cumin (Nigella sativa) oil on TNBS-induced experimental colitis in rats.

Authors:  F Isik; Tugba Tunali Akbay; A Yarat; Z Genc; R Pisiriciler; E Caliskan-Ak; S Cetinel; A Altıntas; G Sener
Journal:  Dig Dis Sci       Date:  2010-07-24       Impact factor: 3.199

2.  Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  H C Reinecker; M Steffen; T Witthoeft; I Pflueger; S Schreiber; R P MacDermott; A Raedler
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

3.  Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer.

Authors:  Wenjie Guo; Yang Sun; Wen Liu; Xingxin Wu; Lele Guo; Peifen Cai; Xuefeng Wu; Xudong Wu; Yan Shen; Yongqian Shu; Yanhong Gu; Qiang Xu
Journal:  Autophagy       Date:  2014-06       Impact factor: 16.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.